Yunjung Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yunjung Kim has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Jeonghoon Ahn
Ewha Womans University
3 shared publications - Byung-Chul Chang
Department of Thoracic and Cardiovascular Surgery, Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 03722, Republic of Korea
2 shared publications - Cheong Lim
Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
2 shared publications - Ho Jin Kim
Division of Cardiac Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
2 shared publications - Ho Young Hwang
Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
2 shared publications - Hyung Gon Je
Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
2 shared publications
Latest Publications
- Open Access
- 13 May 2024
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 40 (1) , e28
Deliberative process of health technology reassessment by health technology assessment agency in Korea
In 2019, the National Evidence-based Healthcare Collaborating Agency (NECA) in Korea established a health technology reassessment (HTR) system to manage the life cycle of health technologies and develop operational measures promoting the efficient use of healthcare resources. The purpose of this study is to introduce the detailed implementation process and practical functional methods of the HTR implemented by NECA. The HTR is a structured multidisciplinary method for analyzing health technologies currently used in the healthcare system based on the latest information on parameters, such as clinical safety, effectiveness, and cost-effectiveness of optimizing the use of healthcare resources as well as social and ethical issues. All decision-making stages of the HTR are carefully reviewed and transparently managed. The HTR committee makes significant decisions, and the subcommittee decides the details related to the assessment process. Since the pilot began in 2018, 262 cases have been reassessed, of which, 126 cases (48.1 percent) were health services not covered by the National Health Insurance (NHI). Over the past 5 years, approximately 130 recommendations for the in-use technologies were determined by the HTR committee. In the near future, it will be necessary to officially develop and establish a Korean HTR system and a legal foundation to optimize the NHI system.
- 13 May 2024
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 40 (1) , e28
Open AccessDeliberative process of health technology reassessment by health technology assessment agency in Korea
In 2019, the National Evidence-based Healthcare Collaborating Agency (NECA) in Korea established a health technology reassessment (HTR) system to manage the life cycle of health technologies and develop operational measures promoting the efficient use of healthcare resources. The purpose of this study is to introduce the detailed implementation process and practical functional methods of the HTR implemented by NECA. The HTR is a structured multidisciplinary method for analyzing health technologies currently used in the healthcare system based on the latest information on parameters, such as clinical safety, effectiveness, and cost-effectiveness of optimizing the use of healthcare resources as well as social and ethical issues. All decision-making stages of the HTR are carefully reviewed and transparently managed. The HTR committee makes significant decisions, and the subcommittee decides the details related to the assessment process. Since the pilot began in 2018, 262 cases have been reassessed, of which, 126 cases (48.1 percent) were health services not covered by the National Health Insurance (NHI). Over the past 5 years, approximately 130 recommendations for the in-use technologies were determined by the HTR committee. In the near future, it will be necessary to officially develop and establish a Korean HTR system and a legal foundation to optimize the NHI system.
- Open Access
- 24 August 2022
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 55 (5) , 415-423
The Primary Process and Key Concepts of Economic Evaluation in Healthcare
Economic evaluations in the healthcare are used to assess economic efficiency of pharmaceuticals and medical interventions such as diagnoses and medical procedures. This study introduces the main concepts of economic evaluation across its key steps: planning, outcome and cost calculation, modeling, cost-effectiveness results, uncertainty analysis, and decision-making. When planning an economic evaluation, we determine the study population, intervention, comparators, perspectives, time horizon, discount rates, and type of economic evaluation. In healthcare economic evaluations, outcomes include changes in mortality, the survival rate, life years, and quality-adjusted life years, while costs include medical, non-medical, and productivity costs. Model-based economic evaluations, including decision tree and Markov models, are mainly used to calculate the total costs and total effects. In cost-effectiveness or costutility analyses, cost-effectiveness is evaluated using the incremental cost-effectiveness ratio, which is the additional cost per one additional unit of effectiveness gained by an intervention compared with a comparator. All outcomes have uncertainties owing to limited evidence, diverse methodologies, and unexplained variation. Thus, researchers should review these uncertainties and confirm their robustness. We hope to contribute to the establishment and dissemination of economic evaluation methodologies that reflect Korean clinical and research environment and ultimately improve the rationality of healthcare policies.
- 24 August 2022
- Published by Korean Society for Preventive Medicine in Journal of Preventive Medicine and Public Health
- Vol. 55 (5) , 415-423
Open AccessThe Primary Process and Key Concepts of Economic Evaluation in Healthcare
Economic evaluations in the healthcare are used to assess economic efficiency of pharmaceuticals and medical interventions such as diagnoses and medical procedures. This study introduces the main concepts of economic evaluation across its key steps: planning, outcome and cost calculation, modeling, cost-effectiveness results, uncertainty analysis, and decision-making. When planning an economic evaluation, we determine the study population, intervention, comparators, perspectives, time horizon, discount rates, and type of economic evaluation. In healthcare economic evaluations, outcomes include changes in mortality, the survival rate, life years, and quality-adjusted life years, while costs include medical, non-medical, and productivity costs. Model-based economic evaluations, including decision tree and Markov models, are mainly used to calculate the total costs and total effects. In cost-effectiveness or costutility analyses, cost-effectiveness is evaluated using the incremental cost-effectiveness ratio, which is the additional cost per one additional unit of effectiveness gained by an intervention compared with a comparator. All outcomes have uncertainties owing to limited evidence, diverse methodologies, and unexplained variation. Thus, researchers should review these uncertainties and confirm their robustness. We hope to contribute to the establishment and dissemination of economic evaluation methodologies that reflect Korean clinical and research environment and ultimately improve the rationality of healthcare policies.
- Open Access
- 5 April 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (2) , 88-98
A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort
Ho Jin Kim, M.D., Joon Bum Kim, M.D., Ph.D., Seon-Ok Kim, M.Sc., Sung-Cheol Yun, Ph.D., Sak Lee, M.D., Ph.D., Cheong Lim, M.D., Ph.D., Jae Woong Choi, M.D., Ho Young Hwang, M.D., Ph.D., Kyung Hwan Kim, M.D., Seung Hyun Lee, M.D., Ph.D., Jae Suk Yoo, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Hyung Gon Je, M.D., Ph.D., Soon Chang Hong, M.D., Ph.D., Yun Jung Kim, R.N., Ph.D., Sung-Hyun Kim, M.S., Byung-Chul Chang, M.D, Ph.D., F.A.H.A.. J Chest Surg 2021;54:88-98. https://doi.org/10.5090/jcs.20.102
- 5 April 2021
- Published by Korean Society for Thoracic and Cardiovascular Surgery in Journal of Chest Surgery
- Vol. 54 (2) , 88-98
Open AccessA Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort
Ho Jin Kim, M.D., Joon Bum Kim, M.D., Ph.D., Seon-Ok Kim, M.Sc., Sung-Cheol Yun, Ph.D., Sak Lee, M.D., Ph.D., Cheong Lim, M.D., Ph.D., Jae Woong Choi, M.D., Ho Young Hwang, M.D., Ph.D., Kyung Hwan Kim, M.D., Seung Hyun Lee, M.D., Ph.D., Jae Suk Yoo, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Hyung Gon Je, M.D., Ph.D., Soon Chang Hong, M.D., Ph.D., Yun Jung Kim, R.N., Ph.D., Sung-Hyun Kim, M.S., Byung-Chul Chang, M.D, Ph.D., F.A.H.A.. J Chest Surg 2021;54:88-98. https://doi.org/10.5090/jcs.20.102
- Open Access
- 18 November 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
A Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort
Ho Jin Kim, M.D., Joon Bum Kim, M.D., Ph.D., Seon-Ok Kim, M.Sc., Sung-Cheol Yun, Ph.D., Sak Lee, M.D., Ph.D., Cheong Lim, M.D., Ph.D., Jae Woong Choi, M.D., Ho Young Hwang, M.D., Ph.D., Kyung Hwan Kim, M.D., Seung Hyun Lee, M.D., Ph.D., Jae Suk Yoo, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Hyung Gon Je, M.D., Ph.D., Soon Chang Hong, M.D., Ph.D., Yun Jung Kim, R.N., Ph.D., Sung-Hyun Kim, M.S., Byung-Chul Chang, M.D, Ph.D., F.A.H.A.. Korean J Thorac Cardiovasc Surg 1999;0:. https://doi.org/10.5090/kjtcs.20.102
- 18 November 2020
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
Open AccessA Risk Prediction Model for Operative Mortality after Heart Valve Surgery in a Korean Cohort
Ho Jin Kim, M.D., Joon Bum Kim, M.D., Ph.D., Seon-Ok Kim, M.Sc., Sung-Cheol Yun, Ph.D., Sak Lee, M.D., Ph.D., Cheong Lim, M.D., Ph.D., Jae Woong Choi, M.D., Ho Young Hwang, M.D., Ph.D., Kyung Hwan Kim, M.D., Seung Hyun Lee, M.D., Ph.D., Jae Suk Yoo, M.D., Ph.D., Kiick Sung, M.D., Ph.D., Hyung Gon Je, M.D., Ph.D., Soon Chang Hong, M.D., Ph.D., Yun Jung Kim, R.N., Ph.D., Sung-Hyun Kim, M.S., Byung-Chul Chang, M.D, Ph.D., F.A.H.A.. Korean J Thorac Cardiovasc Surg 1999;0:. https://doi.org/10.5090/kjtcs.20.102
- 17 July 2018
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 25 (10) , 587-601
Comparative effectiveness of telemonitoring versus usual care for type 2 diabetes: A systematic review and meta-analysis
Aims: This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes. Methods: We searched Ovid-Medline, Ovid-EMBASE, and the Cochrane Library to identify randomized controlled trials that compared telemonitoring and usual care in patients with type 2 diabetes. Results: Thirty-eight studies (6855 patients) were included. Telemonitoring was associated with a significant decrease in glycated haemoglobin levels compared to usual care (weighted mean difference –0.42%, 95% confidence interval –0.56 to –0.27) but there was evidence of heterogeneity ( I2 = 96.9%). Telemonitoring was associated with a significant glycated haemoglobin reduction when biological data were transmitted through a web-based device weekly, when voice feedback was performed daily or immediately and when patients were provided with counselling. Telemonitoring also reduced glycated haemoglobin level in studies that monitored patients’ medication adherence, provided counselling, education and alarm message. The rate of achieving glycated haemoglobin levels of < 7% was 1.8 times higher in the telemonitoring group compared to the usual care group (risk ratio 1.83, 95% confidence interval 1.35 to 2.47, I2 = 0%). There was also significant reduction in systolic blood pressure (weighted mean difference –1.33 mm Hg) and body mass index (weighted mean difference –0.25 kg/m2), but the clinical relevance of these results can be questioned. The data available on patient satisfaction, quality of life, medication adherence, prescription changes, stress and depression were limited. Conclusions: Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes. Further studies should assess clinical benefit according to specific delivery modes of the intervention and patient-reported outcomes.
- 17 July 2018
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 25 (10) , 587-601
Comparative effectiveness of telemonitoring versus usual care for type 2 diabetes: A systematic review and meta-analysis
Aims: This study evaluated clinical effectiveness of telemonitoring on the management of patients with type 2 diabetes. Methods: We searched Ovid-Medline, Ovid-EMBASE, and the Cochrane Library to identify randomized controlled trials that compared telemonitoring and usual care in patients with type 2 diabetes. Results: Thirty-eight studies (6855 patients) were included. Telemonitoring was associated with a significant decrease in glycated haemoglobin levels compared to usual care (weighted mean difference –0.42%, 95% confidence interval –0.56 to –0.27) but there was evidence of heterogeneity ( I2 = 96.9%). Telemonitoring was associated with a significant glycated haemoglobin reduction when biological data were transmitted through a web-based device weekly, when voice feedback was performed daily or immediately and when patients were provided with counselling. Telemonitoring also reduced glycated haemoglobin level in studies that monitored patients’ medication adherence, provided counselling, education and alarm message. The rate of achieving glycated haemoglobin levels of < 7% was 1.8 times higher in the telemonitoring group compared to the usual care group (risk ratio 1.83, 95% confidence interval 1.35 to 2.47, I2 = 0%). There was also significant reduction in systolic blood pressure (weighted mean difference –1.33 mm Hg) and body mass index (weighted mean difference –0.25 kg/m2), but the clinical relevance of these results can be questioned. The data available on patient satisfaction, quality of life, medication adherence, prescription changes, stress and depression were limited. Conclusions: Telemonitoring interventions may be a better option than usual care in improving glycated haemoglobin control of patients with type 2 diabetes. Further studies should assess clinical benefit according to specific delivery modes of the intervention and patient-reported outcomes.
- 1 June 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1
Wearable plasma-pads for healthcare applications: Plasma patch, plasma bandage, plasma socks, and plasma cap
Summary form only given. Wearable plasma-devices involving a dielectric barrier discharge (DBD) are introduced. The conventional devices of the atmospheric pressure plasmas, a DBD and a plasma jet developed last decades, have an inconvenient for some cases requiring a frequent treatment, a long period therapy, and a significantly large area to be exposed with the plasma. The wearable plasma-pads are provided to cover such purposes of an user's description. The flexible plasma-pads are comprised by three-layers: a gauzy cloth at the base, a DBD-plasma texture-layer at the middle, and an antiseptic gauze at the top. The DBD-plasma is generated at the space between the bottom cloth and the top gauze. Many kinds of reactive species including UV penetrate through the gauzy-nets into a skin for therapy. We have two ways of texturing the plasma layer: One is to lay the insulated high voltage-wires which are widely used in the electricity. The other is to use the thin polymer-films of a polyimide film (capton film) or a poly-glass film on which the electrodes are made by pasting or printing the conducting materials. In both cases of a plasma layering a high voltage electrode and a ground electrode are formed by many ways of shapes and structures to generate the uniform plasma on the texture surface. The electric power system is also made to be wearable and portable by a rechargeable battery used in a mobile cellular phone. The high voltage is applied with a frequency of several tens of kHz, a sinusoidal voltage of a few kV in rms value through a DC-AC inverter. The plasma pads provide a various forms of products for the user's purpose: such as plasma patch, plasma bandage, plasma socks, and plasma cap, etc. We have made a various size of a plasma patch of which an adhesive tape is attached around the margin. The plasma patch can stick on the face or the skin of a body like a sticking plaster for dermatology. The plasma laced-bandage is applied to a wound and a skin burn with an accident at the scene for stop bleeding and a blood coagulation to prevent the infection. The socks are worn in the night time for the treatment of a tenea-pedis. The cap is for the hair depilation and hair rejuvenation. We introduce the plasma devices relating the basic structures, the electrical properties, and the spectroscopic analysis.
- 1 June 2016
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 1
Wearable plasma-pads for healthcare applications: Plasma patch, plasma bandage, plasma socks, and plasma cap
Summary form only given. Wearable plasma-devices involving a dielectric barrier discharge (DBD) are introduced. The conventional devices of the atmospheric pressure plasmas, a DBD and a plasma jet developed last decades, have an inconvenient for some cases requiring a frequent treatment, a long period therapy, and a significantly large area to be exposed with the plasma. The wearable plasma-pads are provided to cover such purposes of an user's description. The flexible plasma-pads are comprised by three-layers: a gauzy cloth at the base, a DBD-plasma texture-layer at the middle, and an antiseptic gauze at the top. The DBD-plasma is generated at the space between the bottom cloth and the top gauze. Many kinds of reactive species including UV penetrate through the gauzy-nets into a skin for therapy. We have two ways of texturing the plasma layer: One is to lay the insulated high voltage-wires which are widely used in the electricity. The other is to use the thin polymer-films of a polyimide film (capton film) or a poly-glass film on which the electrodes are made by pasting or printing the conducting materials. In both cases of a plasma layering a high voltage electrode and a ground electrode are formed by many ways of shapes and structures to generate the uniform plasma on the texture surface. The electric power system is also made to be wearable and portable by a rechargeable battery used in a mobile cellular phone. The high voltage is applied with a frequency of several tens of kHz, a sinusoidal voltage of a few kV in rms value through a DC-AC inverter. The plasma pads provide a various forms of products for the user's purpose: such as plasma patch, plasma bandage, plasma socks, and plasma cap, etc. We have made a various size of a plasma patch of which an adhesive tape is attached around the margin. The plasma patch can stick on the face or the skin of a body like a sticking plaster for dermatology. The plasma laced-bandage is applied to a wound and a skin burn with an accident at the scene for stop bleeding and a blood coagulation to prevent the infection. The socks are worn in the night time for the treatment of a tenea-pedis. The cap is for the hair depilation and hair rejuvenation. We introduce the plasma devices relating the basic structures, the electrical properties, and the spectroscopic analysis.
- Open Access
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (1) , 80-88
Venous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry
Lee S, et al. J Korean Med Sci. 2016 Jan;31(1):80-88. https://doi.org/10.3346/jkms.2016.31.1.80
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (1) , 80-88
Open AccessVenous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry
Lee S, et al. J Korean Med Sci. 2016 Jan;31(1):80-88. https://doi.org/10.3346/jkms.2016.31.1.80
- Open Access
- 1 January 2014
- Published by XMLink in Journal of Korean Medical Science
- Vol. 29 (6) , 852-858
Epidemiology of Hip Replacements in Korea from 2007 to 2011
Yoon PW, et al. J Korean Med Sci. 2014 Jun;29(6):852-858. https://doi.org/10.3346/jkms.2014.29.6.852
- 1 January 2014
- Published by XMLink in Journal of Korean Medical Science
- Vol. 29 (6) , 852-858
Open AccessEpidemiology of Hip Replacements in Korea from 2007 to 2011
Yoon PW, et al. J Korean Med Sci. 2014 Jun;29(6):852-858. https://doi.org/10.3346/jkms.2014.29.6.852
- Open Access
- 22 September 2011
- Published by S. Karger AG in Folia Phoniatrica et Logopaedica
- Vol. 64 (1) , 26-33
Effect of Level of Presentation to Listeners on Scaled Speech Intelligibility of Speakers with Dysarthria
Objective: This study examined the effect of intensity level of presentation on scaling of speech intelligibility in speakers with and without dysarthria. Patients and Methods: A total of 50 utterances produced by speakers with dysarthria and healthy speakers were played to 60 listeners in four conditions, which consisted of two different presentation levels (‘high’ vs. ‘low’) and equalization of levels across utterances (‘adjusted’ vs. ‘unadjusted’). Speech intelligibility was scaled by using a direct magnitude estimation technique with and without modulus. Results: A significant decrease in speech intelligibility was indicated when the stimuli were adjusted to have fixed intensity on the most intense vocalic nuclei of each word, while no significant change was found between ‘high’ and ‘low’ presentation level conditions. Conclusion: The findings suggest that an increase in presentation level alone does not result in significant improvement in speech intelligibility ratings. The results are discussed by considering clinical implications in conducting speech therapy with emphasis on intensity variation.
- 22 September 2011
- Published by S. Karger AG in Folia Phoniatrica et Logopaedica
- Vol. 64 (1) , 26-33
Open AccessEffect of Level of Presentation to Listeners on Scaled Speech Intelligibility of Speakers with Dysarthria
Objective: This study examined the effect of intensity level of presentation on scaling of speech intelligibility in speakers with and without dysarthria. Patients and Methods: A total of 50 utterances produced by speakers with dysarthria and healthy speakers were played to 60 listeners in four conditions, which consisted of two different presentation levels (‘high’ vs. ‘low’) and equalization of levels across utterances (‘adjusted’ vs. ‘unadjusted’). Speech intelligibility was scaled by using a direct magnitude estimation technique with and without modulus. Results: A significant decrease in speech intelligibility was indicated when the stimuli were adjusted to have fixed intensity on the most intense vocalic nuclei of each word, while no significant change was found between ‘high’ and ‘low’ presentation level conditions. Conclusion: The findings suggest that an increase in presentation level alone does not result in significant improvement in speech intelligibility ratings. The results are discussed by considering clinical implications in conducting speech therapy with emphasis on intensity variation.